Could pharma’s blockbuster immunotherapies work in dogs?

Roughly 6 million dogs are diagnosed with cancer every year in the U.S. Yet, there aren’t many treatment options. Most chemotherapies in veterinary medicine are human drugs that have been repurposed for dogs and cats with mixed results.

“They’re toxic and they’re expensive,” said Adriann Sax, CEO, president and co-founder of the clinical stage animal health biopharma Vetigenics. “Some pet parents would be willing to … invest $10,000 in chemo.